Frontlight ResearchEarly access
Lung cancer trials in United States
900 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleA Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311)
- Where
- Atlanta, Boston, Gilbert, Los Angeles, Louisville, Memphis, New York, Philadelphia, Pittsburgh, Seattle, Sioux Falls, St Louis, Tampa
- Age
- 18 years to 90 years
- People
- 380 worldwide
- Run by
- Amgen
See details and how to joinNCT07037758 - No phaseTaking peopleDESTINY-PANTUMOUR04
- Where
- Birmingham, Boulder, Bullhead City, Canton, Casa Grande, Coral Springs, Dallas, Decatur, Durham, Farmington, Maumee, Nashville, Philadelphia, San Diego, St. Petersburg, Topeka, West Palm Beach, Wilson
- Age
- 18 years to 130 years
- People
- 100
- Run by
- AstraZeneca
See details and how to joinNCT07124000 - Phase 1/2Taking peoplePh1/2 Trial Of Navlimetostat With Pumitamig In MTAP-Deficient Advanced Non-Small Cell Lung Cancer
- Where
- Houston
- Age
- 18 years and over
- People
- 17
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07579221 - Phase 1Not yet taking people in United StatesA Study to Learn About the Study Medicine Called Ponsegromab in Adults With Lung Cancer-Associated Significant Body Weight Loss
- Where
- Decatur, Garland, Houston, O'Fallon
- Age
- 18 years and over
- People
- 80 worldwide
- Run by
- Pfizer
See details and how to joinNCT07663630 · EU 2026-526002-32-00 - Phase 1/2Taking peopleA Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
- Where
- Boston, Charlotte, Chicago, Columbus, Coral Gables, Denver, Detroit, Fairfax, Houston, Nashville, New York, Orange, Palo Alto, Philadelphia, Sacramento, Seattle, St Louis, Washington D.C.
- Age
- 12 years and over
- People
- 359 worldwide
- Run by
- Nuvalent Inc.
See details and how to joinNCT05118789 · EU 2024-511793-71-00 - Phase 1/2Taking peopleSafety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- Where
- Beverly Hills, Boston, Boynton Beach, Dallas, Glendale, Los Angeles, Nashville, Tacoma
- Age
- 18 years and over
- People
- 134
- Run by
- Neonc Technologies, Inc.
See details and how to joinNCT06047379 - No phaseTaking peopleA Registry for People With Lung Cancer
- Where
- Ann Arbor, Basking Ridge, Boston, Chicago, Commack, Dallas, Evanston, Harrison, Houston, Middletown, Montvale, New York, Philadelphia, Pittsburgh, San Diego, Tucson, Uniondale
- Age
- 18 years and over
- People
- 600 worldwide
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT06424327 - No phaseTaking peoplePan-tumor MRD Study
- Where
- Atlanta, Binghamton, Birmingham, Bullhead City, Canton, Casa Grande, Charlotte, Coral Springs, Corbin, Covington, Elizabethtown, Englewood, Farmington, Glendale, Goldsboro, Grand Rapids, Houston, Kingwood, Lancaster, Lexington, Lincoln, Little Rock, Louisville, Maumee, O'Fallon, Orange City, Oxnard, Portland, Richmond, Rochester, San Diego, Sayre, Shirley, Shreveport, Springdale, Springfield, Stockton, St. Petersburg, Tacoma, Texarkana, Topeka, Tulsa, Urbana, Wichita, Wilson, York
- Age
- 18 years and over
- People
- 1,350
- Run by
- Paradigm Health
See details and how to joinNCT06605404 - Phase 2Taking peopleAn Adjuvant Study to Evaluate SMS001 (Paclitaxel) in Non-Small Cell Lung Cancer
- Where
- Rochester
- Age
- 18 years to 80 years
- People
- 42 worldwide
- Run by
- ToLymph Inc.
See details and how to joinNCT06693336 - Phase 1Taking peopleA Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
- Where
- New Have, Santa Monica
- Age
- 18 years and over
- People
- 76 worldwide
- Run by
- Kivu Bioscience Inc.
See details and how to joinNCT07229313 - No phaseNot yet taking people in United StatesMIND-WELL Intervention
- Where
- Tucson
- Age
- 18 years and over
- People
- 80
- Run by
- University of Arizona
See details and how to joinNCT07839325 - Phase 2Taking peopleA Study of ZEN003694 in People With Squamous Cell Lung Cancer
- Where
- Basking Ridge, Commack, East White Plains, Middletown, Montvale, New York, Uniondale
- Age
- 18 years and over
- People
- 13
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT05607108 - Phase 1/2Taking peopleA Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
- Where
- Birmingham, Cleveland, Columbus, Hackensack, Iowa City, Irving, Knoxville, Miami, Pittsburgh, Portland, Seattle, St Louis
- Age
- 18 years and over
- People
- 416 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06618287 - Phase 3Taking peopleA Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- Where
- Bethlehem, Birmingham, Blacksburg, Boston, Chicago, Duarte, Edina, Eugene, Fairfax, Fairfield, Fort Myers, Goodyear, Grand Rapids, Houston, Indianapolis, Irvine, Knoxville, Louisville, Madison, Memphis, Mobile, Morgantown, Mullica Hill, Nashville, Newnan, Orlando, Peoria, Pinehurst, Portland, Rochester, Springfield, Tampa, Tyler, Winchester, Zion
- Age
- 18 years and over
- People
- 531 worldwide
- Run by
- AbbVie
See details and how to joinNCT07365241 · EU 2025-523819-11-00 - Phase 1/2Taking peopleA Study of Risvutatug Rezetecan in Combination With Ivonescimab in Participants With Advanced Solid Tumors (EMBOLD PanTumour-103)
- Where
- Canton, Los Angeles, Wilson
- Age
- 18 years and over
- People
- 184 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07602855 - No phaseTaking peopleBright Light Therapy in Patients With Melanoma or Non-small Cell Lung Cancer (NSCLC) Who Are Receiving First-Line Immune Checkpoint Blockade
- Where
- New York
- Age
- 18 years and over
- People
- 12
- Run by
- Weill Medical College of Cornell University
See details and how to joinNCT07661966 - Phase 2Taking peopleQuick Start Durvalumab Following Chemoradiation for Stage III Nonsmall Cell Lung Cancer
- Where
- Charlotte, Winston-Salem
- Age
- 18 years and over
- People
- 28
- Run by
- Wake Forest University Health Sciences
See details and how to joinNCT05696782 - Phase 1/2Taking peopleStudy of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Where
- Aurora, Boston, Dallas, Detroit, Duarte, Fairfax, Grand Rapids, Houston, Indianapolis, Irving, Nashville, New York, Oklahoma City, Orange, Pittsburgh, Sacramento, San Antonio, Sarasota, Stanford, Tampa
- Age
- 18 years and over
- People
- 534 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT06128551 - Phase 1Taking peopleA Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)
- Where
- Chicago, Duarte, Irvine, Los Angeles, Nashville, New York, Orange, Philadelphia, Santa Monica, St Louis
- Age
- 18 years and over
- People
- 232 worldwide
- Run by
- AbbVie
See details and how to joinNCT06858813 · EU 2024-518012-39-00 - Phase 1Taking peoplePhase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
- Where
- Boston, Iowa City, Royal Oak, Seattle
- Age
- 18 years to 100 years
- People
- 116 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07006727 · EU 2024-519111-34-00 - No phaseTaking peopleProspective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer
- Where
- Albuquerque, Coeur d'Alene, Dover, Elk Grove Village, Houston, Milford, Monterey, Paoli, Torrance, Walnut Creek
- Age
- 18 years and over
- People
- 130
- Run by
- N-Power Medicine
See details and how to joinNCT07028489 - Phase 2Taking peoplePulmonary Rehabilitation in Advanced Lung Cancer Survivors
- Where
- Cleveland
- Age
- 18 years and over
- People
- 85
- Run by
- Case Comprehensive Cancer Center
See details and how to joinNCT07104630 - No phaseTaking peopleA Community Health Intervention to Improve Lung Cancer Screening Uptake in Community Health Centers
- Where
- Springfield
- Age
- 50 years to 80 years
- People
- 120
- Run by
- Baystate Medical Center
See details and how to joinNCT07168629 - No phaseTaking peopleAn External Control Arm Study in Non-Small Cell Lung Cancer
- Where
- Albuquerque, Barrington, Dover, Elk Grove, Hoffman Estates, Houston, Milford, Monterey, New York, Rolling Meadows, Wynnewood
- Age
- 18 years and over
- People
- 650
- Run by
- N-Power Medicine
See details and how to joinNCT07174388 - No phaseTaking peopleQualitative Study on Detection & Tx of NSCLC in Pts w/ a History of Alcohol or SUD
- Where
- Los Angeles
- Age
- 18 years and over
- People
- 45
- Run by
- University of Southern California
See details and how to joinNCT07186699